| Date | Title | Description |
| 25.07.2017 | Regenerative medicine startup Rodeo Therapeutics raises $5.9M for drugs to regenerate tissue | Dr. Sanford Markowitz, founder of Rodeo Therapeutics. (Case Western Reserve University Photo)
If you could write a medical wish-list of futuristic technologies, regenerating tissue would be pretty high up there. It could do things like trea... |
| 13.07.2017 | Every Major Seattle Accelerator and Incubator, Listed | TechCo has compared accelerators to band camp in the past: You're stuck in a location with a bunch of your peers whether you like them or not, work hard, play hard, and take snack breaks. And by the time it ends, you've built a lasting netw... |
| 12.12.2016 | ApoGen secures $7M Series A with Accelerator Corporation | On Monday, the firm announced its third and final investment of the year, ApoGen Biotechnologies, with $7 million in new funding to begin its development journey with Accelerator.
“We’re not quite an incubator, we’re not quite a venture cap... |
| 12.12.2016 | Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy | - |
| 21.10.2016 | Accelerator Expands Operations with New Institution Partners Industry Veterans | Accelerator Corporation, a Seattle, WA- and New York City-based based life science investment and management firm, expanded operations with three new institution partners and the appointment of a life science veteran.
CoMotion at the Univer... |
| 05.05.2016 | AgTech Accelerator: Taking Early Stage Funding to New Heights with Syngenta, Bayer and 8 Universities | As agriculture technology has increasingly crept into the psyche of entrepreneurs and venture investors globally, the number of groups popping up to support the development of startups in the space has grown exponentially.
By our count, the... |
| 11.01.2016 | Lodo Therapeutics Raises $17M in Series A Funding | Lodo Therapeutics Corporation, a NYC-based company that develops novel therapeutics derived from its metagenomics-based small molecule discovery platform, raised $17m in Series A funding.
Backers included AbbVie, Alexandria Venture Investme... |
| 11.01.2016 | Life science investment group Accelerator Corp. backs two New York startups | Accelerator Corp. CEO Thong Le.
Fresh off a $62.8 million round of funding, Seattle-based life sciences investment company Accelerator Corp. is backing two new biotech startups.
Earlier this month, Accelerator Corp. announced a $48 million ... |
| 11.01.2016 | Accelerator Corporation Launches Lodo Therapeutics with $17 Million Series A | - |
| 06.01.2016 | Petra Pharma Raises $48M in Series A Funding | Petra Pharma Corporation, a New York City-based developer of small molecule inhibitors for the treatment of cancer and metabolic diseases, raised $48 million in Series A funding.
Backers included AbbVie, Alexandria Venture Investments, ARCH... |
| 29.09.2015 | Accelerator Corp.’s fourth fund expands to $62.8M for life science investment | It’s located in the Alexandria Center for Life Science, the city’s first and only science park. However, New York is positioning itself as a life sciences hub and it’ll undoubtedly be aided by having a local accelerator to invest in transla... |
| 29.09.2015 | Accelerator Corporation Completes $62.8 Million Oversubscribed Financing | - |
| 29.09.2015 | Accelerator Secures Additional $11.7M | Accelerator Corporation, a life science investment and management firm, secured an additional $11.7m in new investment commitments.
This final closing, which brought the final Accelerator IV closing to $62.8m, included new strategic investm... |
| 25.03.2015 | Mapping Seattle’s incubators, accelerators and co-working spaces | Inside the UW’s new Startup Hall, home to Techstars Seattle and a co-working space.
With the birth of Y Combinator in Silicon Valley a decade ago, the number of accelerators, incubators, and co-working spaces has increased exponentially ove... |
| 06.08.2014 | Three new life sciences accelerators in the works, Alexandria Real Estate CEO says | “We have different investor syndicates for each accelerator,” Marcus said, adding that the ag tech accelerator will be backed by companies in the food production industry, the digital health startup will be backed by companies in that space... |
| 29.07.2014 | Biotechnology investor Accelerator Corp. lands $51 million, expands in New York City | Thong Le
Accelerator Corp, the Seattle biotechnology investment fund started in Seattle 11 years ago, has raised $51.1 million in capital as part of a first closing of its fourth fund. Accelerator also announced plans to expand operations i... |
| 29.01.2014 | Biotech investor Thong Le named CEO of Accelerator Corp. | Thong Le
Thong Le has taken the helm of Accelerator Corp., the Seattle-based investment firm that bankrolls emerging startups in the biotechnology arena. Le has served on the board of the organization for the past six years, but with the sh... |
| 29.03.2013 | Seattle biotech ups series B again to ID & develop antibodies as infectious disease therapies | Its lead antibody, being developed in a partnership with Zenyaku Kogyo, is a treatment for severe hospitalized flu and for the national pandemic stockpile. It’s in a phase 2, proof-of-concept study now with data anticipated this year.
Flu t... |
| 14.06.2012 | Biotech startup VLST raises $5M | VLST Corp., a Seattle biotech developing therapeutics for the treatment of autoimmune and inflammatory diseases, has raised an additional $5 million in venture capital financing, according to a SEC filing today. The company could raise anot... |
| 12.12.2011 | Groove Biopharma Raises $6M in Series B Financing | Groove Biopharma, a Seattle, WA-based biotechnology company focused on the generation of novel microRNA (miRNA) based therapeutics, has raised $6m in Series B financing.
Backers include Alexandria Venture Investments, ARCH Venture Partners,... |
| 24.05.2011 | Oncofactor Corporation Raises Series A Funding | Oncofactor Corporation, a Seattle, WA-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system, has raised an undisclosed amount in Series A funding.
This is the twelfth company backed by v... |
| 11.05.2011 | Do You Really Need an Incubator? Join the Debate at XSITE on June 16 | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Although nobody seems to like the term “incubator”—mostly because of failures from the dot-com era—it’s clear that mentorship and accelerator programs like Y Combinator, TechS... |
| 26.04.2010 | Mirina Corporation Closes Series A-1 Financing | Mirina Corporation, a Seattle, WA-based biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, has closed a Series A-1 financing.
The round was led by new investor Versant Ventures. ... |
| 14.03.2008 | Life-science briefing: Friday, March 14, 2008 | TODAY’S HEADLINES
Cantimer takes in $2M for dehydration diagnostics (VentureWire)
Recodagen launches, takes aim at cancer (release)
Juniper Diagnostics spins out of ChemSensing (VentureWire)
Cantimer takes in $2M for dehydration diagnostics... |
| 26.10.2007 | Life sciences briefing: Friday, Oct. 26, 2007 | Featured companies: Allozyne, Arteriocyte Medical Systems, Arthrosurface, Bay City Capital, EnteroMedics, OncoVista, Novotech, Power Medical Interventions, Reliant Technologies
UPDATED: Expanded items on Allozyne, Reliant Tech, Power Medica... |
| 03.08.2007 | Accelerator incubator raises $23M for new biotech investments | Accelerator, a Seattle biotech incubator linked to the Institute for Systems Biology, raised $22.5 million in a third funding round. The round was led by Amgen Ventures, Arch Venture Partners and OVP Venture Partners, joined by Alexandria R... |
| - | Accelerator Corp.’s fourth fund expands to $62.8M for life science investment | Accelerator Corp., a New York and Seattle-based life sciences investment firm, just added $11.7 million to its fourth fund – bringing it to an oversubscribed round of $62.8 million. It’s focused on investing in new therapeutics.
The new cas... |
| - | Three new life sciences accelerators in the works, Alexandria Real Estate CEO says | Alexandria Real Estate is developing three new accelerators around the country, aiming to launch startups in the agricultural, digital health and biotech spaces, CEO Joel Marcus told MedCity News.
The life sciences real estate development f... |
| - | ApoGen secures $7M Series A with Accelerator Corporation | Many life science venture firms pride themselves on being involved, rolling up their sleeves and symbolically claiming several board positions.
Accelerator Corporation takes it to a whole new level, with a full incubator-like service that s... |
| - | Seattle biotech ups series B again to ID & develop antibodies as infectious disease therapies | Seattle-based biotech Theraclone Sciences Inc. has added another $8 million to its series B as it advances two antibodies targeting viral infections through clinical development and works on identifying more.
Existing investors ARCH Venture... |
